Cell Death Induction Mechanism of Non-small Cell Lung Cancer Cell Line, NCI-H1703 by Docetaxel |
Ha Hyeon-Cheol
(Department of Thoracic and Cardiovascular Surgery, Collage of Medicine, Pusan National University)
Song Seung-Hwan (Department of Thoracic and Cardiovascular Surgery, Collage of Medicine, Pusan National University) Park Chin-Su (Department of Thoracic and Cardiovascular Surgery, Collage of Medicine, Pusan National University) Kim Jong-Won (Department of Thoracic and Cardiovascular Surgery, Collage of Medicine, Pusan National University) Kim Yeong-Dae (Department of Thoracic and Cardiovascular Surgery, Collage of Medicine, Pusan National University) |
1 | Calderoni A, Cerny T. Taxanes in lung cancer. A review with focus on the European experience. Crit Rev Oncol Hematol 2001;38:105-27 DOI ScienceOn |
2 | Yoon SJ, Lee H, Shin Y, Kim YI, Kim CY, Chang H. Estimation of the burden of major cancers in Korea. J Korean Med Sci 2002;17:604-10 DOI |
3 | Zelivianski S, Spellman M, Kellerman M, et al. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int J Cancer 2003;107:478-85 DOI ScienceOn |
4 | Illidge TM, Cragg MS, Fringes B, Olive P, Erenpreisa JA. Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage. Cell Biol Int 2000;24: 621-33 DOI ScienceOn |
5 | Huisman C, Ferreira CG, Broker LE, et al. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCL-H460. Clin Cancer Res 2002;8:596 |
6 | Ferreira CG, Tolis C, Span SW, et al. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. Clin Cancer Res 2000;6: 203-12 |
7 | Herbst RS, Khuri FR. Mode of action of docetaxel - a basis for combination with novel anticancer agents. Cancer Treat Rev 2003;29:407-15 DOI ScienceOn |
8 | Ganansia-Leymarie V, Bischoff P, Bergerat JP, Holl V. Signal transduction pathways of taxanes-induced apoptosis. Curr Med Chem Anti-Canc Agents 2003;3:291-306 DOI ScienceOn |
9 | Cullen M. Lung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning. Thorax 2003;58: 352-6 DOI ScienceOn |
10 | Langer CJ. Advanced non-small cell lung carcinoma: the emerging role of docetaxel. Invest New Drugs 2000;18: 17-28 DOI ScienceOn |
11 | Masuda A, Maeno K, Nakagawa T, Saito H, Takahashi T. Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by antimicrotubule agents in human lung cancers. Am J Pathol 2003;163:1109-16 DOI ScienceOn |
12 | Georgoulias V. Docetaxel (taxotere) in the treatment of nonsmall cell lung cancer. Curr Med Chem 2002;9:869-77 DOI ScienceOn |
13 | Weigel TL, Lotze MT, Kim PK, Amoscato AA, Luketich JD, Odoux C. Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity. J Thorac Cardiovasc Surg 2000;119:795-803 DOI ScienceOn |
14 | Chang JC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362: 362-9 DOI ScienceOn |
15 | Morris SM. A role for p53 in the frequency and mechanism of mutation. Mutat Res 2002;511:45-62 DOI ScienceOn |
16 | King TC, Akerley W, Fan AC, et al. p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma. Cancer 2000;89:769-73 DOI ScienceOn |
17 | Kolfschoten GM, Hulscher TM, Duyndam MC, Pinedo HM, Boven E. Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel. Biochem Pharmacol 2002;63:733-43 DOI ScienceOn |
18 | Wang H. Combined effect of docetaxel and cisplatin for nonsmall cell lung cancer cell lines in vitro. Nagoya J Med Sci 2000;63:129-37 |